Basics C4 Therapeutics, Inc. IPO Date: October 2, 2020 Sector: Healthcare Industry: Biotech Market Cap: $246.16M Activated in VL: True Average Daily Range Avg Daily Range: $0.47 | 3.96% Avg Daily Range (30 D): $0.09 | 3.59% Avg Daily Range (90 D): $0.11 | 4.42% Institutional Daily Volume Avg Daily Volume: 1.37M Avg Daily Volume (30 D): 1.43M Avg Daily Volume (90 D): 1.78M Trade Size Avg Trade Size (Sh.): 140 Avg Trade Size (Sh.) (30 D): 193 Avg Trade Size (Sh.) (90 D): 199 Institutional Trades Total Inst.Trades: 1,050 Avg Inst. Trade: $1.94M Avg Inst. Trade (30 D): $3.07M Avg Inst. Trade (90 D): $2.4M Avg Inst. Trade Volume: .21M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.19M Avg Closing Trade (30 D): $1.72M Avg Closing Trade (90 D): $1.2M Avg Closing Volume: 187.24K     News Nov 25, 2025 @ 12:00 PM C4 Therapeutics to Participate in the 8th Annual E... Source: C4 Therapeutics Sep 15, 2025 @ 10:33 PM Why C4 Therapeutics Stock Crushed the Market on Mo... Source: Eric Volkman May 7, 2025 @ 11:00 AM C4 Therapeutics Reports First Quarter 2025 Financi... Source: C4 Therapeutics Jan 29, 2025 @ 6:00 PM BRAF Inhibitors Market to Register Incremental Gro... Source: Delveinsight Jan 9, 2025 @ 3:53 PM NUT Midline Carcinoma Treatment Market Research Re... Source: Researchandmarkets.Com Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.44 $-.37 $-.37 Diluted EPS $-.44 $-.37 $-.37 Revenue $ 11.23M $ 6.46M $ 7.24M Gross Profit $ $ $ Net Income / Loss $ -32.17M $ -26.02M $ -26.32M Operating Income / Loss $ -34.41M $ -28.5M $ -29.16M Cost of Revenue $ $ $ Net Cash Flow $ -19.35M $ 26.86M $ -4.21M PE Ratio